跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tamplus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tamplus
Approved
STANDARD
Tamplus
Ajanta Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c38f1f46fdb0854a
Company
Ajanta Pharma Limited
Type
Standard
Approval Details
Approval Id
c38f1f46fdb0854a
Drug Approval Philippines Name
Tamplus
Product Name
Tamplus
Registration Number
DR-XY38883
Brand Name
Tamplus
Generic Name
Tamsulosin Hydrochloride + Finasteride
Dosage Form
Sustained-Release Capsule
Dosage Strength
400mcg/5mg
Manufacturer
Ajanta Pharma Limited
Importer
Ajanta Pharma Philippines, Inc.
Distributor
Ajanta Pharma Philippines, Inc.
Company Detail Path
/organization/ajanta-pharma-limited
Issuance Date
27 May 2022
Expiry Date
23 December 2025
Pharmacologic Category
Benign Prostatic Hypertrophy Drug Combination (Alpha-adrenoceptor Antagonist and Testosterone-5 alpha Reductase Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c38f1f46fdb0854a
Type
Standard
Back to Philippines FDA Approvals